Osteopontin B and C Splice Isoforms in Leukemias and Solid Tumors: Angiogenesis Alongside Chemoresistance Publisher Pubmed



Mirzaei A¹ ; Mohammadi S^{1, 2} ; Ghaffari SH¹ ; Yaghmaie M^{1, 2} ; Vaezi M^{1, 2} ; Alimoghaddam K^{1, 2} ; Ghavamzadeh A^{1, 2} Show Affiliations
Source: Asian Pacific Journal of Cancer Prevention Published:2018

Abstract

Osteopontin (OPN) is a glycoprotein involved in regulation of various influences on tumor progression, such as cellular proliferation, apoptosis, angiogenesis, and metastasis. Vascular endothelial growth factor (VEGF) is a secreted molecule supporting angiogenesis in various cancers through activation of the PI3K/AKT/ERK1/2 pathway. OPN and VEGF have a number of isoforms with various activities. In spite of the well-defined association between OPN and VEGF isoform expression and cure rate for solid tumors, there is a scarcity of information as to any association in leukemia. Based on the critical role of OPN in cell survival, it seems reasonable to hypothesize that OPN and VEGF isoform expression levels may impact on chemoresistance and relapse in leukemia the same as in solid tumors. Hence, the aim of our review was to explain relationships between OPN and VEGF isoforms and angiogenesis and related pathways in chemoresistance of leukemia and solid tumors. Our findings demonstrated that OPNb and OPNc alongside with VEGF isoforms and other gene pathways are involved in angiogenesis and also might promote chemoresistance and even recurrence in leukemia and solid tumors. To sum up, targeting OPN isoforms, particularly b and c, might be a novel therapeutic strategy for the treatment of leukemia as well as solid tumors. © Asian Pacific Journal of Cancer Prevention, 2017.